Skip to main content

Table 1 Baseline characteristics in untreated and treated MS groups

From: Influence of Interferon beta treatment on quality of life in multiple sclerosis patients

Variable

Covariate

Untreated

IFN-β treated

p-value

No. of patients

 

77

41

 

Age at disease onset (yrs)

 

30.3 ± 9.7

28.7 ± 10.5

0.42

Age at inclusion (yrs)

 

42.1 ± 11.2

36.8 ± 11.5

0.02

Gender

Male

28 (36.4)

8 (19.5)

0.06

 

Female

49 (63.6)

33 (80.5)

 

Disease duration (yrs)

 

12.0 ± 7.8

8.9 ± 8.1

0.04

Disease course

RR

58 (75.3)

34 (82.9)

0.34

 

SP

19 (24.7)

7 (17.1)

 

School education (degree-yrs)

<5

10 (12.9)

6 (14.6)

0.97

 

6–8

16 (21)

7 (17.1)

 
 

9–13

38 (49.2)

19 (46.3)

 
 

>13

13 (16.9)

9 (22)

 
  1. Data are expressed as means ± SD or n (%). P-values refer to T test or Pearson χ2.